{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "340",
                "346"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Acesan"
        },
        {
            "identifier": "T2",
            "position": [
                "348",
                "358"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Thiopental"
        },
        {
            "identifier": "T3",
            "position": [
                "510",
                "516"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Acesan"
        },
        {
            "identifier": "T4",
            "position": [
                "517",
                "532"
            ],
            "subtype": "Drug_dose",
            "type": "T",
            "value": "30mg 1xdziennie"
        },
        {
            "identifier": "T5",
            "position": [
                "536",
                "573"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "Zg\u0142oszenie si\u0119 do Kliniki Kardiologii"
        },
        {
            "identifier": "T6",
            "position": [
                "574",
                "592"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "w dniu 04.02.2018r"
        },
        {
            "identifier": "T7",
            "position": [
                "634",
                "641"
            ],
            "subtype": "Investigation",
            "type": "T",
            "value": "angioTK"
        },
        {
            "identifier": "T8",
            "position": [
                "843",
                "852"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Cefazolin"
        },
        {
            "identifier": "T9",
            "position": [
                "854",
                "863"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Tiopental"
        },
        {
            "identifier": "T10",
            "position": [
                "983",
                "989"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Acesan"
        },
        {
            "identifier": "T11",
            "position": [
                "1126",
                "1132"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Acesan"
        },
        {
            "identifier": "T12",
            "position": [
                "1133",
                "1149"
            ],
            "subtype": "Drug_dose",
            "type": "T",
            "value": "30mg 1x dziennie"
        },
        {
            "identifier": "T13",
            "position": [
                "1299",
                "1324"
            ],
            "subtype": "Symptom",
            "type": "T",
            "value": "w  stanie    do\u015b\u0107  dobrym"
        },
        {
            "identifier": "T14",
            "position": [
                "1410",
                "1416"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Acesan"
        },
        {
            "identifier": "T15",
            "position": [
                "1555",
                "1574"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "wrodzon\u0105 wad\u0105 serca"
        },
        {
            "identifier": "T16",
            "position": [
                "1651",
                "1666"
            ],
            "subtype": "Symptom",
            "type": "T",
            "value": "Stan do\u015b\u0107 dobry"
        },
        {
            "identifier": "T17",
            "position": [
                "1805",
                "1824"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "wrodzon\u0105 wad\u0105 serca"
        },
        {
            "identifier": "T18",
            "position": [
                "1901",
                "1916"
            ],
            "subtype": "Symptom",
            "type": "T",
            "value": "Stan do\u015b\u0107 dobry"
        },
        {
            "identifier": "T19",
            "position": [
                "611",
                "632"
            ],
            "subtype": "Investigation",
            "type": "T",
            "value": "bada\u0144 diagnostycznych"
        },
        {},
        {
            "icd": "ICD10:Q20",
            "identifier": "N1",
            "referenced": "T15",
            "subtype": "Reference",
            "type": "N",
            "value": "Wrodzone wady rozwojowe jam i po\u00c5\u0082\u00c4\u0085cze\u00c5\u0084 sercowych"
        },
        {
            "icd": "ICD10:Q20",
            "identifier": "N2",
            "referenced": "T17",
            "subtype": "Reference",
            "type": "N",
            "value": "Wrodzone wady rozwojowe jam i po\u00c5\u0082\u00c4\u0085cze\u00c5\u0084 sercowych"
        },
        {
            "arg1": "T3",
            "arg2": "T4",
            "identifier": "R1",
            "subtype": "Drg",
            "type": "R"
        },
        {
            "arg1": "T6",
            "arg2": "T5",
            "identifier": "R2",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T11",
            "arg2": "T12",
            "identifier": "R4",
            "subtype": "Drg",
            "type": "R"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 1 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: \u017ce\u0144ska\n------------------------------------------------\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nAcesan, Thiopental\n------------------------------------------------\nZalecenia\n------------------------------------------------\n1) Dalsze regularne przyjmowanie leku:\n    Acesan 30mg 1xdziennie\n2) Zg\u0142oszenie si\u0119 do Kliniki Kardiologii w dniu 04.02.2018r. w celu wykonania bada\u0144 diagnostycznych (angioTK), po wcze\u015bniejszym telefonicznym potwierdzeniu przybycia w sekretariacie Kliniki.\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nCefazolin, Tiopental\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nAcesan\n------------------------------------------------\nZalecenia\n------------------------------------------------\nKontynuacja podawania leku: Acesan 30mg 1x dziennie.\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nDziecko  9  miesi\u0119czne  w  stanie    do\u015b\u0107  dobrym  zosta\u0142a przyj\u0119ta  do  Kliniki  celem przeprowadzenia  bada\u0144 kontrolnych\nOtrzymuje   Acesan\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nDziewczynka z wrodzon\u0105 wad\u0105 serca przyj\u0119ta do Kliniki do poszerzonych bada\u0144 i ustalenia dalszego post\u0119powania Stan do\u015b\u0107 dobry\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nDziewczynka z wrodzon\u0105 wad\u0105 serca przyj\u0119ta do Kliniki do poszerzonych bada\u0144 i ustalenia dalszego post\u0119powania Stan do\u015b\u0107 dobry\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nPotas: K:5.00[mmol/L]\nPotas: K:4.40[mmol/L]\nS\u00f3d: Na:137.00[mmol/L]\nS\u00f3d: Na:139.00[mmol/L]\nRKZ Parametry krytyczne\n    pH:7.291\n    pCO2:38.2[mmHg]\n    BE:-7.80[mmol/L]\n    HCO3:17.8[mmol/L]\n    pO2:31.6[mmHg]\n    O2Sat:45.4[%]\n    COMMENT_HL7:\nMorfologia\n    WBC:12.70[10\\\\^3/ul]\n    RBC:5.59[10\\\\^6/ul]\n    HGB:14.2[g/dl]\n    HCT:42.4[%]\n    MCV:75.8[fl]\n    MCH:25.4[pg]\n    MCHC:33.5[g/dl]\n    PLT:332.0[10\\\\^3/ul]\n    RDW-SD:41.1[fl]\n    RDW-CV:15.1[%]\n    PDW:10.5[fl]\n    MPV:9.7[fl]\n    P-LCR:21.7[%]\n    PCT:0.3[%]\n    NEUTR#:2.64[10\\\\^3/ul]\n    NEUTR%:20.8[%]\n    LYMPH#:7.40[10\\\\^3/ul]\n    LYMPH%:58.3[%]\n    MONO#:0.56[10\\\\^3/ul]\n    MONO%:4.40[%]\n    EO#:2.06[10\\\\^3/ul]\n    EO%:16.20[%]\n    BASO#:0.04[10\\\\^3/ul]\n    BASO%:0.30[%]\n    NRBC %:0.10[%]\n    NRBC#:0.01[10\\\\^3/ul]\nMorfologia\n    WBC:13.04[10\\\\^3/ul]\n    RBC:5.84[10\\\\^6/ul]\n    HGB:14.4[g/dl]\n    HCT:44.1[%]\n    MCV:75.5[fl]\n    MCH:24.7[pg]\n    MCHC:32.7[g/dl]\n    PLT:265.0[10\\\\^3/ul]\n    RDW-SD:40.4[fl]\n    RDW-CV:14.9[%]\n    PDW:10.8[fl]\n    MPV:10.1[fl]\n    P-LCR:24.6[%]\n    PCT:0.3[%]\n    NEUTR#:3.15[10\\\\^3/ul]\n    NEUTR%:24.1[%]\n    LYMPH#:7.43[10\\\\^3/ul]\n    LYMPH%:57.0[%]\n    MONO#:0.75[10\\\\^3/ul]\n    MONO%:5.80[%]\n    EO#:1.64[10\\\\^3/ul]\n    EO%:12.60[%]\n    BASO#:0.07[10\\\\^3/ul]\n    BASO%:0.50[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nMorfologia\n    WBC:8.52[10\\\\^3/ul]\n    RBC:6.22[10\\\\^6/ul]\n    HGB:16.1[g/dl]\n    HCT:47.2[%]\n    MCV:75.9[fl]\n    MCH:25.9[pg]\n    MCHC:34.1[g/dl]\n    PLT:206.0[10\\\\^3/ul]\n    RDW-SD:36.9[fl]\n    RDW-CV:13.6[%]\n    PDW:11.2[fl]\n    MPV:10.0[fl]\n    P-LCR:24.9[%]\n    PCT:0.2[%]\n    NEUTR#:4.05[10\\\\^3/ul]\n    NEUTR%:47.4[%]\n    LYMPH#:3.00[10\\\\^3/ul]\n    LYMPH%:35.2[%]\n    MONO#:0.95[10\\\\^3/ul]\n    MONO%:11.20[%]\n    EO#:0.49[10\\\\^3/ul]\n    EO%:5.80[%]\n    BASO#:0.03[10\\\\^3/ul]\n    BASO%:0.40[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nABL Parametry krytyczne\n    pH:7.321\n    pCO2:47.8[mmHg]\n    BE:-2.10[mmol/L]\n    HCO3:24.0[mmol/L]\n    pO2:21.6[mmHg]\n    O2Sat:25.4[%]\n    Na - ABL:138[mmol/L]\n    K - ABL:5.3[mmol/L]\n    Cl - ABL:109[mmol/L]\n    Ca zj ABL:1.36[mmol/L]\n    Ht - ABL:48.5[%]\n    Hb ABL:15.8[g/dl]\n    FO2Hb:25.2[%]\n    FCOHb:0.1[%]\n    FMetHb:0.5[%]\n    FHbF - ABL:*[%]\n    GLU-ABL:98[mg/dl]\n    mleczany:33[mg/dl]\n    COMMENT_HL7:\nImmununochemia -Immulite: COMMENT_HL7:\nD-dimery t. ilo\u015bciowy: D-dimer:425.0[ng/ml]\nD-dimery t. ilo\u015bciowy: D-dimer:1916.0[ng/ml]\nFibrynogen (F): FIB:2.12[g/L]\nFibrynogen (F): FIB:1.88[g/L]\nFibrynogen (F): FIB:3.06[g/L]\nAntytrombina III (ATIII): ATIII:106.0[%]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:26.1[s]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:25.3[s]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:28.0[s]\nINR: INR:1.1\nINR: INR:1.1\nINR: INR:1.1\nCzas protrombinowy (PT): PT:12.6[s]\nCzas protrombinowy (PT): PT:11.8[s]\nCzas protrombinowy (PT): PT:12.0[s]\nCzas trombinowy (TT): TT:15.6[s]\nCzas trombinowy (TT): TT:15.3[s]\nChlorki: Cl:107.00[mmol/L]\nWap\u0144 ca\u0142kowity: Ca:2.46[mmol/L]\nMagnez: Mg:0.77[mmol/L]\nMagnez: Mg:0.76[mmol/L]\nWska\u017anik wysycenia Fe %: wsk%Fe:17.24[%]\nUIBC-utajona zdolno\u015b\u0107 wi\u0105zania \u017celaza: UIBC:312.00[ug/dl]\nCholesterol: CHOL:119.00[mg/dl]\nBilirubina ca\u0142kowita TBIL: TBIL:0.10[mg/dl]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nWska\u017anik PT: PT%:87[%]\nWska\u017anik PT: PT%:93[%]\nWska\u017anik PT: PT%:92[%]\nGlukoza - ABL: GLU-ABL:*[mg/dl]\nTIBC: TIBC:377.00[ug/dl]\nFe: Fe:65.00[ug/dl]\nKreatynina: CREA:0.30[mg/dl]\nKreatynina: CREA:0.30[mg/dl]\nKreatynina: CREA:0.40[mg/dl]\nMocznik: UREA:34.00[mg/dl]\nMocznik: UREA:22.00[mg/dl]\nMocznik: UREA:39.00[mg/dl]\nCholesterol LDL (met.bezpo\u015brednia): LDL:68.00[mg/dl]\nCholesterol HDL: HDL:44.00[mg/dl]\nASPAT: AST:48.00[IU/L]\nASPAT: AST:41.00[IU/L]\nASPAT: AST:46.00[IU/L]\nALAT: ALT:34.00[IU/L]\nALAT: ALT:33.00[IU/L]\nALAT: ALT:41.00[IU/L]\nPLT z morfologii: PLT:332.0[10\\\\^3/ul]\nPLT z morfologii: PLT:265.0[10\\\\^3/ul]\nNT- proBNP: NTpBNP:127.00[pg/ml]\nTSH: TSH:5.37[uIU/ml]\nGlukoza w surowicy: GLU-sur:121[mg/dl]\nPosiew - Wymaz z nosa: POSIEW:\nPosiew - Wymaz z odbytu: POSIEW:\nWzrost pacjenta: WzrostPac:72[cm]\nWzrost pacjenta: WzrostPac:72[cm]\nWzrost pacjenta: WzrostPac:77[cm]\neGFR (do 1r\u017c) wg Schwartza wsp. 0.413: eGFRdo1r\u017c:99.1[ml/min/1,73m2]\neGFR (do 1r\u017c) wg Schwartza wsp. 0.413: eGFRdo1r\u017c:99.1[ml/min/1,73m2]\neGFR (do 1r\u017c) wg Schwartza wsp. 0.413: eGFRdo1r\u017c:79.5[ml/min/1,73m2]\nFT3 III: FT3 III:4.45[pg/ml]\nFT4II: FT4II:1.31[ng/dl]\nGrupa krwi + p/c odporno\u015bciowe (powy\u017cej 4. m-ca \u017cycia\n    NR-KS:G-18/020238\n    KODKRESKOWYPROBKI:G-18/020238\n    GR:O\n    RH:+ (dodatni)\n    FENOTYP:K-\n    P-CIALA:Przeciwcia\u0142 odporno\u015bciowych dla antygen\u00f3w krwinek czerwonych nie stwierdzono.\nMorfologia krwi + PLT rozdzia\u0142 5 cz\u0119\u015b\u0107 WBC\n    WBC Krwinki bia\u0142e:9.68[10^3/ul]\n    RBC Krwinki czerwone:5.78[10^6/ul]\n    HGB Hemoglobina:15.4[g/dl]\n    HCT Hematokryt:45.2[%]\n    MCV wska\u017anik czerwonokrw:78.2[fl]\n    MCH wska\u017anik czerwonokrw:26.6[pg]\n    MCHC wska\u017anik czerwonokr:34.1[g/dl]\n    PLT z morfologii:186[10^3/ul]\n    RDW-SD:39.3[fl]\n    RDW-CV:14.0[%]\n    PDW:10.6[fl]\n    MPV:10.0[fl]\n    P-LCR:22.9[%]\n    PCT (hematokryt p\u0142ytkowy:0.19[%]\n    NEUTR# warto\u015b\u0107 bezwzgl\u0119d:5.91[10^3/ul]\n    NEUTR%:61.0[%]\n    LYMH# warto\u015b\u0107 bezwzgl\u0119dn:2.39[10^3/ul]\n    LYMPH%:24.7[%]\n    MONO# warto\u015b\u0107 bezwzgl\u0119dn:0.77[10^3/ul]\n    MONO%:8.0[%]\n    EO# warto\u015b\u0107 bezwzgl\u0119dna:0.56[10^3/ul]\n    EO%:5.8[%]\n    BASO# warto\u015b\u0107 bezwzgl\u0119dn:0.05[10^3/ul]\n    BASO%:0.5[%]\n    NRBC %:0.0[%]\n    NRBC #:0.00[10^3/ul]\nAntytrombina III: Antytrombina III:89[%]\nCzas kaolinowo-kefalinowy (APTT): APTT-SP:29.9[sek]\nCzas protrombinowy (PT)\n    Czas protrombinowy:11.6[sek]\n    Wska\u017anik PT:94.8[%]\n    INR:1.05\nCzas trombinowy TT: Czas trombinowy TT:14.5[sek]\nFibrynogen: Fibrynogen:2.99[g/L]\nD-dimer - test ilo\u015bciowy: D-dimer - test ilo\u015bciowy:461[ng/ml]\nALAT: ALAT:15[U/L]\nASPAT: ASPAT:45[U/L]\nBilirubina ca\u0142kowita (TBil): Bilirubina ca\u0142kowita:0.50[mg/dl]\nCRP Bia\u0142ko C-reaktywne: CRP Bia\u0142ko C-reaktywne:0.55[mg/dl]\nS\u00f3d (Na): S\u00f3d:139[mmol/L]\nPotas (K): Potas:4.3[mmol/L]\nFosforany nieorganiczne: Fosforany nieorganiczne:1.47[mmol/L]\nKreatynina + GFR\n    Kreatynina w surowicy:0.27[mg/dl]\n    eGFR stand. wg Schwartza:169.1[ml/min/1,73 m^2]\n    wzrost:83[cm]\nMagnez: Magnez:0.77[mmol/L]\nMocznik: Mocznik:21[mg/dl]\nWap\u0144 ca\u0142kowity: Wap\u0144 ca\u0142kowity:2.35[mmol/L]\nR\u00f3wnowaga Kwasowo-Zasadowa (RKZ)\n    pH:7.335\n    pCO2:36.9[mmHg]\n    BE:-5.60[mmol/L]\n    HCO3:19.1[mmol/L]\n    pO2:37.1[mmHg]\n    O2Sat:62.3[%]\nGlukoza w surowicy: Glukoza w surowicy:90[mg/dl]\nNT-proBNP surowica: NT-proBNP w surowicy:237[pg/ml]\n------------------------------------------------\nICD10\n------------------------------------------------\nQ22.1\nZ98.8\nQ20.1\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n88.721\n87.411\n87.440\n------------------------------------------------"
}